Abstract
Invasive mould infections are a major cause of infectious mortality in highly immunosuppressed patients. Incidence in this high risk group is 10-20% with a death rate in excess of 50%. Most invasive moulds are Aspergillus spp. We present a case of a 74-year-old woman with acute lymphoblastic leukaemia who developed a rare disseminated mould infection with Fusarium solani during induction chemotherapy. We present the case story and discuss the pathogenesis, clinical characteristics and treatment of invasive fusariosis.
Bidragets oversatte titel | Disseminated fusariosis in a patient with acute lymphoblastic leukaemia |
---|---|
Originalsprog | Dansk |
Tidsskrift | Ugeskrift for Laeger |
Vol/bind | 170 |
Udgave nummer | 37 |
Sider (fra-til) | 2892 |
Antal sider | 2 |
ISSN | 0041-5782 |
Status | Udgivet - 8 sep. 2008 |
Emneord
- Aged
- Antifungal Agents/administration & dosage
- Antineoplastic Combined Chemotherapy Protocols/adverse effects
- Dermatomycoses/drug therapy
- Fatal Outcome
- Female
- Fusarium/isolation & purification
- Humans
- Immunocompromised Host
- Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy